The Journal of Toxicological Sciences · 2014 · 10 citations · 53 references
MedicineOncologyPharmacologyApoptosisChemotherapyTumor MicroenvironmentAdipocyte DifferentiationCancer Cell SignalingCancer MetabolismCancer Stem CellsCytotoxic ChemotherapyTumor Microenvironment ModulationAdipocyte BiologyC-jun N-terminal Kinase SignalingCell Death In CancerJnk Pathway ActivationJnk Signaling PathwayJun N-terminal Kinase SignalingTargeted Therapy-induced ApoptosisTumor-associated Adipocytes
Recent evidence shows that tumor microenvironment containing heterogeneous cells may be involved in cancer initiation, growth and tumor cell response to anticancer therapy. Chemotherapy was designed to make toxic impact on malicious cells in organisms, however, the means to protect healthy cells against chemical toxicity are still unsuccessful. As known, the majority of tumor surrounding cells are cancer-associated adipocytes which influence cancer development, progression and treatment. Targeting the components of tumor microenvironment in combination with conventional cancer treatment may become an effective cancer therapy strategy. However, little is known about adipocyte death mechanisms during combined chemo- and targeted therapy. The importance of c-Jun-NH<inf>2</inf>-terminal kinase (JNK) signaling in tumor development and treatment has been demonstrated using various in vitro and in vivo cancer models. The aim of this study was to ascertain adipocyte viability during simultaneous stress kinase JNK inhibition and exposure to one of the most commonly used anticancer drugs cis-diamminedichloroplatinum II (cisplatin). Our model involved adipocyte-like cells (ADC) which were obtained during in vitro differentiation of adult rabbit muscle-derived stem cells. Cisplatin induced apoptotic cell death. During 24-hr cisplatin treatment gradual, strong and prolonged increase of both JNK and its target protein c-Jun phosphorylation was found in ADC. Pre-treatment of cells with SP600125 decreased cisplatin-induced activation of c-Jun and promoted apoptosis. Upregulation of proapoptotic Bax and downregulation of antiapoptotic Bcl-2 proteins were found to be regulated in JNK-dependent manner. Thus, the results prove the antiapoptotic role of activated JNK in adipocyte-like cells treated with cisplatin.
53
A central role for JNK in obesity and insulin resistance
Jiro Hirosumi, Gürol Tuncman, Lufen Chang et al. · Nature · 2002 · 3.3K citations
Diverse somatic mutation patterns and pathway alterations in human cancers
Zhengyan Kan, Bijay S. Jaiswal, Jeremy Stinson et al. · Nature · 2010 · 1K citations
Bcl-2 Phosphorylation Required for Anti-apoptosis Function
Takahiko Ito, Xingming Deng, Boyd K. Carr et al. · Journal of Biological Chemistry · 1997 · 541 citations · Full text